Manufacturer (m/f/d)
Adragos Pharma LeipzigLeipzig, Saxony, Germany
Posted October 23, 2024
Full-time
About the Company
Adragos Pharma is a CDMO company that produces medicines for millions of patients worldwide and is expanding rapidly with a dynamic growth strategy.
Job Description
Our Offer
A varied field of work
Flat hierarchies, short decision-making processes
Performance-based remuneration and employer-supported occupational pension plan beyond the statutory framework
Accident insurance also for private accidents
Free parking
Free drinks
Job ticket, job bike
Your Tasks
- Execution of individual production steps (weighing, production) in the production of semi-solid and liquid dosage forms
- Operation and maintenance of equipment and measuring instruments
- Execution of in-process controls
- Operation of the water treatment plant (reverse osmosis)
- GMP-compliant documentation (production protocols, logbooks, etc.)
- Cleaning of process equipment, equipment, and rooms
Contact
Completed vocational training (e.g. pharmacist, chemist, PTA or similar training from the food industry)
First work experience in the food, cosmetics, or pharmaceutical industry
Solid hygiene and GMP knowledge
Technical understanding
Meticulous and reliable working method
Flexibility, team skills, and commitment
German language skills
Readiness for shift work (no weekends)
Apply for this Job
About us
Adragos Pharma was founded in 2020 with the goal of becoming one of the leading CDMOs in the small molecule field worldwide.
We are pursuing our Buy&Build growth strategy with great pressure: Within the next 3-5 years, we will acquire and integrate production facilities in Europe and North America to achieve our goal of becoming a market leader.
CDMOs (Contract Development and Manufacturing Organization) produce about 25% of all medicines available in pharmacies and clinics and therefore play a crucial role in global medication supply for millions of patients.
Due to the increasing pressure on the healthcare system (demographic change, spread of chronic diseases, etc.), CDMOs will become even more important in the future.
Since 2020, we have expanded our team from three to over 700 employees worldwide and are now successfully connected with Private Equity, FSN Capital, and a leading German family office, Prange Group.
We have so far acquired five production and development sites in Germany, France, Greece, Norway, and Japan - and you will also become part of our dynamic growth and apply now!
